申请人:CAULFIELD Thomas J.
公开号:US20100113462A1
公开(公告)日:2010-05-06
The present invention relates to novel compounds of the formula I:
wherein in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
本发明涉及公式I的新化合物:其中在其任何立体异构形式或立体异构形式的混合物中以任何比例,或其生理上可接受的盐,其中取代基如此描述。这些创新化合物具有CXCR5抑制活性,特别适用于治疗或预防各种炎症性疾病,例如类风湿性关节炎,多发性硬化症,红斑狼疮,克罗恩病,与人类CXCR5受体调节相关。